Option chain shows key data for Cosciens Biopharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Cosciens Biopharma.

Cosciens Biopharma (NASDAQ:CSCI) Stock, Option Chain

Cosciens Biopharma

AEterna Zentaris

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.

10 Highest-Paying Dividend Stocks In The S&P 500

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

AAMC

ADXN

AMWD

CSCI

ENSC

VOXX

S&amp;P 500 Edges Higher; American Woodmark Shares Slide

Energy stocks

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Intraday Update

HAIN

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

Wall Street US stocks

LIXT

SCSC

US Stocks Mixed; ScanSource Reports Weak Q4 Results

Cosciens Biopharma Inc

Press Releases

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

COSCIENS Biopharma Announces Change to Board of Directors

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization

COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product

COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents

COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order

COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer

TSX:CSCI

Comments

Cosciens Biopharma

Cosciens Biopharma (CSCI) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell